论文部分内容阅读
胎肝细胞输注(FLT)治疗再生障碍性贫血(下称“再障”)是一种较新的、探索性的疗法。我院自1985年4月开始用 FLT治疗再障,至1986年底有22例接受治疗,除5例在 FLT 后1～2周内自动出院或死亡者外,17例已经观察5～24个月,现将初步结果报告如下。
Fetal hepatocyte infusion (FLT) treatment of aplastic anemia (hereinafter referred to as “aplastic anemia”) is a relatively new, exploratory therapy. In our hospital since April 1985 FLT treatment of aplastic anemia, by the end of 1986, 22 cases were treated, except 5 cases were discharged or died within 1 to 2 weeks after FLT, 17 cases have been observed for 5 to 24 months , The preliminary results are reported below.